Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objectives: To determine the association between ertapenem and resistance of Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae and Acinetobacter baumannii-calcoaceticus complex to different antimicrobials while adjusting for relevant hospital factors.
Methods: This was a retrospective time-series study conducted at a tertiary care centre from September 2002 to August 2008. The specific impact of ertapenem on the resistance of these Gram-negative bacilli (GNB) was assessed by multiple linear regression analysis, adjusting for the average length of stay, rate of hospital-acquired infections and use of 10 other antimicrobials, including type 2 carbapenems.
Results: Unadjusted analyses revealed significant increases over the duration of the study in the number of GNB resistant to meropenem/imipenem among 1000 isolates each of E. coli (0.46 ± 0.22, P < 0.05), P. aeruginosa (6.26 ± 2.26, P < 0.05), K. pneumoniae (8.06 ± 1.50, P < 0.0005) and A. baumannii-calcoaceticus complex (25.39 ± 6.81, P < 0.0005). Increased resistance to cefepime (and other extended-spectrum cephalosporins) was observed in E. coli (9.55 ± 1.45, P < 0.0005) and K. pneumoniae (15.21 ± 2.42, P < 0.0005). A. baumannii-calcoaceticus complex showed increased resistance to all antimicrobials except amikacin. After controlling for confounders, ertapenem was not significantly associated (P > 0.05) with changes in resistance for any pathogen/antimicrobial combination.
Conclusions: After controlling for confounders, ertapenem was not associated with changes in resistance in a group of sentinel GNB, although significant variations in resistance to different antimicrobials were observed in the unadjusted analyses. These results emphasize the importance of implementation of local resistance surveillance platforms and stewardship programmes to combat the global emergence and spread of antimicrobial resistance.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/jac/dku471 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Trends in carbapenem antibiotics utilization, costs, and market dynamics in Medicaid: a retrospective analysis from 1991 to 2023.
Front Med (Lausanne)
August 2025
Department of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim, Saudi Arabia.
Background: Carbapenems are vital antibiotics used to treat severe infections, particularly those caused by multidrug-resistant organisms. Understanding their utilization, reimbursement, and pricing trends is critical to inform healthcare policies and ensure sustainable access. This study aimed to analyze longitudinal trends in carbapenem use, market dynamics, and economic impact within Medicaid from 1991 to 2023.
View Article and Find Full Text PDFExploring the Association of Antimicrobial Use with Resistance Rates via Multiple Linear Regression.
Infect Drug Resist
August 2025
Department of Pharmacy, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, Zhejiang, People's Republic of China.
Purpose: To investigate the macro-level quantitative relationship between resistance and antimicrobial consumption one quarter in advance, aiming to curb resistance and optimize antimicrobial use.
Patients And Methods: A retrospective analysis was conducted on resistance rates and antimicrobial consumption data from our hospital. Multiple linear regression models were employed to identify independent linear correlations between resistance rates and defined daily doses (DDDs) of specific antimicrobials.
Identification of bla- and bla- Positive Multi-Drug Resistant Mixta calida Isolates from Distinct Human Hosts.
Int J Med Microbiol
August 2025
Antimicrobial Resistance and Microbial Ecology Group, School of Medicine, University of Galway, Galway, Ireland; Centre for One Health, Ryan Institute, University of Galway, Galway, Ireland. Electronic address:
Objective: This study aimed to investigate the identification of bla-positive multidrug-resistant Mixta calida isolates from human hosts and to elucidate their genomic determinants in a species-wide context.
Methods: Two carbapenemase-producing M. calida isolates were received by the Galway Reference Laboratory Service in Ireland between June and July 2024.
Impact of Adherence With In-Patient Prospective Audit and Feedback Recommendations on Patient and Economic Outcomes.
J Assoc Med Microbiol Infect Dis Can
March 2025
Medicine and Lab Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
Introduction: Prospective audit and feedback (PAF) are an antimicrobial stewardship intervention that reduces use of broad-spectrum antimicrobials among in-patients. The objective of this study was to assess the impact of adherence to PAF recommendations on the duration of broad-spectrum antimicrobials and patient outcomes.
Methods: This retrospective cohort study included adult in-patients at two tertiary care hospitals in St.
Impact of hypoalbuminemia on patients receiving ertapenem combination therapy for methicillin-susceptible Staphylococcus aureus bacteraemia.
J Antimicrob Chemother
July 2025
Antibiotic Management Program, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Background: Ertapenem combination therapy has been associated with a faster time to blood culture sterilization in patients with MSSA bacteraemia. However, guidance documents advise avoiding ertapenem in patients with a serum albumin level of <2.5 g/dL for Gram negative infections given that ertapenem is highly protein bound and patients with hypoalbuminemia may experience suboptimal ertapenem exposures.
View Article and Find Full Text PDF